Polycythemia Developed in 15% of Patients Using SGLT-2 Inhibitors Tags SGLT-2 Inhibitor Read more about Polycythemia Developed in 15% of Patients Using SGLT-2 Inhibitors
Dapagliflozin Linked to Lower LAVI in Early Diabetic Cardiomyopathy Tags Cardiomyopathy SGLT-2 Inhibitor Read more about Dapagliflozin Linked to Lower LAVI in Early Diabetic Cardiomyopathy
CGM-Guided Insulin Titration Improved Glycemic Control After Kidney Transplant Tags CKD Rapid acting Continuous glucose monitoring (CGM) Read more about CGM-Guided Insulin Titration Improved Glycemic Control After Kidney Transplant
GLP-1RAs and SGLT2 Inhibitors Showed Favorable Liver Outcomes in T2DM Tags GLP-1 agonists MASLD/MASH SGLT-2 Inhibitor Thiazolidinediones Read more about GLP-1RAs and SGLT2 Inhibitors Showed Favorable Liver Outcomes in T2DM
SABRE Model Stratified HF Benefit With SGLT2i in Type 2 Diabetes Tags ASCVD CKD SGLT-2 Inhibitor Type 2 Diabetes with Heart Failure Read more about SABRE Model Stratified HF Benefit With SGLT2i in Type 2 Diabetes
Safety Profiles Differed Across SGLT2i, GLP-1 RA, and DPP-4i Tags DPP-4 inhibitors GLP-1 agonists SGLT-2 Inhibitor Read more about Safety Profiles Differed Across SGLT2i, GLP-1 RA, and DPP-4i
SGLT2 Inhibitors Did Not Worsen LUTS in Type 2 Diabetes Tags Diabetic Nephropathy SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Did Not Worsen LUTS in Type 2 Diabetes
SGLT2i Associated With Lower HHF, CV Death Risk in PAD Tags Coronary artery disease Peripheral vascular disease SGLT-2 Inhibitor Read more about SGLT2i Associated With Lower HHF, CV Death Risk in PAD
SGLT2 Inhibitors Not Linked to Higher UTI Risk After Ileal Urinary Diversion Tags Diabetic Nephropathy SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Not Linked to Higher UTI Risk After Ileal Urinary Diversion
Bexagliflozin Shows Comparable Efficacy to Most SGLT2 Inhibitors in T2DM Tags SGLT-2 Inhibitor Read more about Bexagliflozin Shows Comparable Efficacy to Most SGLT2 Inhibitors in T2DM